Αποτελέσματα Αναζήτησης
Download Medicare Reimbursement Guide. If you have questions related to Cardiolite ® reimbursement, please call (800) 362-2668 (Option 3) or email reimbursement@lantheus.com. Lantheus cannot guarantee coverage or payment for products or procedures.
- Two Day Stress/Rest
Two Day Stress/Rest - Reimbursement - Cardiolite
- Risk Stratification
*Based on a prospective study of 5,807 consecutive patients,...
- Imaging Protocols
Imaging Protocols. Suggested Cardiolite ® One-Day...
- Prescribing Information
Prescribing Information - Reimbursement - Cardiolite
- Perfusion and Function
Myocardial Perfusion and Function assessed by a Gated...
- Patients
Patients - Reimbursement - Cardiolite
- Two Day Stress/Rest
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
CARDIOLITE® is a myocardial perfusion agent indicated for: • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects)
16 Δεκ 2021 · A new table in the CPT book clarifies what is included in the revised codes and the new parentheticals are under these codes: 93653, 93654 and 93656. The Evaluation and Management section of the CPT book features new introductory language, revised codes and a new section with codes for principal care management services.
Billing for the radiopharmaceutical agents: 1. Radiopharmaceuticals are available in unit dose or in bulk doses, the latter requiring preparation at the imaging center. Use of radiopharmaceuticals is regulated by the Nuclear Regulatory Commission (NRC) under strict procedures and guidelines.
25 Μαρ 2024 · Cardiolite package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Myocardial Imaging: Cardiolite ® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing ...